Leading Off
TIPS, TRENDS & NEWS YOU CAN USE
LATEST FINAL RULE ENABLES REPORTING FLEXIBILITY
CMS Eases CEHRT Implementation
By Jeff Grant
In recognizing that many EHR vendors, eligible professionals (EPs) and practices were struggling to have 2014 Edition Certified EHR Technology (CEHRT) implemented in time to complete an EHR incentive program reporting period in 2014, the Centers for Medicare & Medicaid Services and the Office of the National Coordinator for Health Information Technology recently provided a final rule that enables healthcare providers flexibility in how they attest to CEHRT for the 2014 reporting period. In addition, the recently released final rule extends the deadline for Stage 2 meaningful use (MU) requirements until the end of 2016. This means Stage 3 MU will not start for anyone until 2017.
So, what is this flexibility?
Healthcare professionals now have the option of using the 2011 Edition CEHRT, a combination of the 2011 Edition CEHRT and the 2014 Edition CEHRT, or a 2014 Edition CEHRT for the 2014 reporting period. In addition, the final rules states that if you haven’t been able to “fully implement” a 2014 Edition CEHRT, you could go back to an earlier quarter this year (Q1 or Q2) and attest with your 2011 Edition CEHRT.
Depending on the stage of MU you were scheduled to meet this year and which option applies to you (or which option you choose), you can determine whether you should use Stage 1 2013 Rules (including 2013 CQM’s), Stage 1 2014 Rules (including 2014 CQM’s) or Stage 2 2014 Rules (including 2014 CQM’s) for the 2014 reporting period. (For clarity, see “CEHRT Systems Available For Use in 2014,” on page 12.)
If you were scheduled to demonstrate: | You would be able to attest for Meaningful Use: | ||
Using 2011 Edition CEHRT to do: | Using 2011&2014 Edition CEHRT to do: | Using 2014 Edition CEHRT to do: | |
Stage 1 in 2014 | 2013 Stage 1 objective and measures* | 2013 Stage 1 objectives and measures* or 2014 Stage 1 objectives and measures* |
2014 Stage 1 objective and measures |
Stage 2 in 2014 | 2013 Stage 1 objective and measures* | 2013 Stage 1 objectives and measures* or 2014 Stage 1 objectives and measures* or Stage 2 objectives and measures* |
2014 Stage 1 objective and measures* or Stage 2 objective and measures |
*Only providers that could not fully implement 2014 Edition CEHRT for the EHR reporting period in 2014 due to delays in 2014 Edition CEHRT availability. |
Giving You the BUSINESS
■ To generate word-of-mouth referrals, e-mail patients a week after seeing them, and ask about their experience with your practice and whether they would refer others. Be sure to include a link to your practice website and social media sites, so they can provide a testimonial.
— Melinda Emerson, www.inc.com, June 8, 2014
■ To avoid losing your temper at work, attempt to view the situation as a third party; remain calm; be mindful of what, how and where you say what you say; and, if needed, walk away so you can come back with a fresh perspective.
— Jacqueline Whitmore, www.entrepreneur.com, Aug. 25, 2014
■ To become an excellent public speaker, teach the audience something they may not know, share personal stories, use more pictures than text, vary your pitch, tone and pace, be mindful of your body language, share the stage with colleagues, and practice the presentation.
— Carmine Gallo, www.forbes.com, July 22, 2014
■ Employee interest in tasks keeps them motivated and effective, while maintaining their mental gas tanks. As a result, to achieve your goals, you must keep your employees engaged.
— Paul A. O’Keefe, www.nytimes.com, Sept. 5, 2014
A caveat: This chart pertains to providers who could “not fully implement” 2014 Edition CEHRT for the EHR reporting period in 2014 due to delays in 2014 Edition CEHRT availability, as shown at its bottom. “Not fully implement” means awaiting additional updates to a 2014 CEHRT, new version testing by the EP/practice, staff training, workflow modifications and “issues” with your 2014 Edition CEHRT.
Further, the final rule states that if the EP is using a 2014 Edition CEHRT and was scheduled to meet Stage 2 MU this year, but is unable to meet the measure of providing an electronic summary of care upon transition of care due an inability to get DIRECT e-mail addresses from some of the providers to whom they refer patients, he or she is permitted to use Stage 1 2014 rules instead with supporting documentation in the form of a letter or e-mail from the other provider that he or she doesn’t have a direct e-mail.
What this means for O.D.s: the Final Rule probably allows you to “roll back” to a previous version and to use a previous stage.
Mr. Grant is president & founder, Healthcare Management & Automation Systems, Inc.
RESEARCH Notes
■ Lifetime outdoor activities may contribute to exfoliation syndrome (XFS), says September’s JAMA Ophthalmology. Specifically, those who work over water or snow sans sun protection appear to expose their eyes to light from reflective surfaces, causing XFS.
■ The combination of endoscopic cyclophotocoagulation and cataract surgery resulted in reduced IOP and a greater decrease in glaucoma drugs vs. cataract surgery alone, reveals August’s Journal of Cataract & Refractive Surgery.
■ Although observational studies suggest vitamin E and selenium supplementation may prevent cataracts, September 18’s JAMA Ophthalmology. reveals long-term daily supplementation in men is unlikely to have a large beneficial effect on age-related cataract.
Essilor Creates Eye Health Information App
Essilor of America has developed the AskAboutEyes app to enable consumers to anonymously access pertinent information about their eyes before visiting an ECP.
To provide comprehensive content, Essilor joined forces with AllAboutVision.com and Paul Karpecki, O.D., F.A.A.O., who will manage a network of ECPs to ensure app users receive timely and precise answers and advice regarding their eye health, the company says. (Doctors interested in being considered should e-mail AskAboutEyes@essilorusa.com).
“ . . . Many consumers like to feel informed and prepared before meeting with an eyecare professional,” says Essilor of America’s senior vice president of customer development Howard Purcell, O.D., F.A.A.O., Dipl. “The AskAboutEyes app will allow consumers to easily learn more about their options in a convenient way, while helping them find a practitioner who can deliver the expertise they need when making these important healthcare decisions.”
The app, which is not intended as a diagnostic tool or to take the place of the ECP, is expected to launch later this year as a free download on the App Store and Google Play, Essilor of America says.
Researchers Ask: Are You Perceived as Trustworthy?
Although it’s critical for clinicians to gain their patients’ trust, new research in the Journal of Neuroscience suggests our brain’s automatically respond to a face’s trustworthiness before it is consciously perceived.
Specifically, the researchers discovered that specific amygdala regions of the brain showed activity tracking how untrustworthy a face appeared, while other amygdala regions showed activity tracking the trustworthiness signal’s overall strength (be it trustworthy or untrustworthy), despite the fact that the subjects were unable to consciously see any of the series of faces to which they were exposed.
While O.D.s cannot control these snap judgements, research does provide four gestures to avoid if you want to appear trustworthy to patients: crossed arms, face touching, hand touching and leaning backward, reveals a study in Psychological Science.
Specifically, the study’s researchers found that when these gestures were used during a game between two individuals, the receiver of the gestures rated the person who expressed them as less trustworthy vs. when the non-verbal cues weren’t used. Also, an increased frequency in these gestures increased this distrustful feeling by the receiver. The results were the same when a humanoid robot was used to express these non-verbal cues during a conversation with a human participant.
What this means for O.D.s: Be mindful of your gestures. They may affect patients’ wellbeing (distrust in your recommendations) and conversely, your practice’s bottom line.
O.D. Notebook
Schools:
■ The Salus University Pennsylvania College of Optometry (PCO) now offers a three-year Doctor of Optometry degree program. The program is a “highly selective” scholars program, with the first class of 10 scheduled to graduate in June 2017, the school says.
Associations:
■ The AOA released a press release that it disagrees with a Conference Board report that O.D.s will be in short supply through the next decade. The AOA’s Workforce Study reveals an adequate supply of O.D.s.
■ Essilor of America, through Optometry Cares — the AOA Foundation, is sponsoring the Bernard Maitenaz Scholarship, which provides $10,000 to a third-year optometry school student. The Scholarship, which is named for the Varilux lens inventor, will be given annually to one winner. For information on eligibility, visit http://bit.ly/1wKiDqV.
■ Optometry Cares – The AOA Foundation invites fourth-year optometry students to apply for the Dr. Pat & Patrick Cummings $5,000 Scholarship. For additional information, visit www.aoafoundation.org.
■ The Vision Council has appointed R. Michael (Mike) Daley as its CEO as of this month. Mr. Daley retired as president and COO of Essilor’s Lens Division in 2008 and has since held board member and leadership positions with an array of optical organizations, such as Prevent Blindness.
Company News:
■ ABB Optical Group has named Aaron See vice president of marketing. Prior to this appointment, Mr. See was vice president of marketing at Johnson & Johnson’s Vision Care division in Japan.
■ Alcon is donating $50,000 to Essilor Vision Foundation’s Kids Vision for Life, which focuses on eliminating poor vision as a hurdle to learning in children, after getting 50,000 “likes” on its eyeSOLUTION Facebook page.
■ In the Allergan-sponsored 2014 M3 Global Research Survey of Glaucoma Specialists, three in four glaucoma specialists ranked efficacy, tolerability, safety and managed care coverage as the most important when prescribing adjunctive therapy. Visit http://bit.ly/1nz2crw for additional information.
■ CooperVision, Inc. announced it has become a Patriot-level sponsor of the Armed Forces Optometric Society. The Society’s mission is to improve the eye care of the military and their family via education and communication with the O.D.s who serve them.
■ Envision President and CEO Michael Monteferrante is one of four recipients of Boise State University’s 2014 Distinguished Alumni Award. The award is given to alumni who have achieved great success professionally, personally and in support of the university.
■ A Transitions Optical survey reveals unauthorized lens substitutions occur despite the fact that ECPs place a high value on brands when making a recommendation to patients. Also, the survey shows that high-quality frame and lens brands are almost as important as a thorough and accurate eye exam when it comes to patient satisfaction.
■ Vision-Ease Lens, manufacturer of LifeRX and Coppertone polarized lenses, among others, has been acquired by Wind Point Partners, a Chicago-based private equity investment firm.
■ Vision Source has entered into a vision service provider agreement with Minuteman Health, an HMO based in Boston made up of more than 7,500 hospitals, physicians and specialists.